ADMA Biologics Follows Up On RI-002 [Seeking Alpha]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Seeking Alpha
Summary ADMA Biologics (NASDAQ: ADMA ) is a company with a market cap ranging from $100 million to $200 million in the past year, focused on developing innovative products for patients prone to infection. The company develops plasma-based biologics candidates for treatment of Primary Immune Deficiency Disease (PIDD) and the treatment of infectious diseases. In a new interesting development, ADMA recently acquired the assets of Biotest Pharmaceuticals in June 2017, consolidating into a commercial plasma products company with FDA licensed products, source plasma collection, contract manufacturing opportunities, and even some temporary funding. ADMA's late-stage lead candidate, RI-002 , has been held up due to an FDA manufacturing warning letter, and the company plans to resubmit its Biologics License Application (BLA) upon its resolution. The general details for ADMA were covered in a previous article by Strong Bio in April 2017. PIDD has an estimated prevalence of 1 in
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- Adma Biologics: Q1 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
- Adma Biologics (ADMA) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024GlobeNewswire
ADMA
Earnings
- 5/9/24 - Beat
ADMA
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/15/24 - Form ARS
- ADMA's page on the SEC website